Literature DB >> 22005513

Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era.

Krow Ampofo1, Andrew T Pavia, Chris R Stockmann, Anne J Blaschke, Hsin Yi Cindy Weng, Kent E Korgenski, Judy Daly, Carrie L Byington.   

Abstract

From 1996 to 2009, we analyzed changes in pneumococcal disease (PD) in Utah children aged <18 years using International Classification of Diseases, ninth revision coded hospital discharges. We observed a sustained decrease in the incidence of PD among children <5 years in 2001-2004 (-36%) and 2005-2009 (-34%) compared with 1996-2000 (pre-7-valent pneumococcal conjugate vaccine). Decreases were primarily in bacteremia, uncomplicated pneumonia, and meningitis. In contrast, significant increases in complicated pneumonia/empyema were noted in children <5 years (+95% and +85%) and 5 to 17 years (+2% and +70%). Despite decreases in PD among Utah children, complicated pneumonia/empyema has increased during the 7-valent pneumococcal conjugate vaccine era.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22005513      PMCID: PMC4435669          DOI: 10.1097/INF.0b013e318232ee3e

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  13 in total

1.  An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations.

Authors:  Carrie L Byington; LaShonda Y Spencer; Timothy A Johnson; Andrew T Pavia; Daniel Allen; Edward O Mason; Sheldon Kaplan; Karen C Carroll; Judy A Daly; John C Christenson; Matthew H Samore
Journal:  Clin Infect Dis       Date:  2002-01-03       Impact factor: 9.079

2.  Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.

Authors:  Carrie L Byington; Matthew H Samore; Gregory J Stoddard; Steve Barlow; Judy Daly; Kent Korgenski; Sean Firth; David Glover; Jasmin Jensen; Edward O Mason; Cheryl K Shutt; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2005-05-26       Impact factor: 9.079

3.  Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-03-12       Impact factor: 17.586

4.  Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types.

Authors:  Melinda M Pettigrew; Kristopher P Fennie; Matthew P York; Janeen Daniels; Faryal Ghaffar
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  Epidemiology of invasive pneumococcal disease in Kumasi, Ghana.

Authors:  Richard E Holliman; Helen Liddy; Julie D Johnson; Ohene Adjei
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-11-28       Impact factor: 2.184

6.  Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.

Authors:  Katherine K Hsu; Kimberly M Shea; Abbie E Stevenson; Stephen I Pelton
Journal:  Pediatr Infect Dis J       Date:  2010-04       Impact factor: 2.129

7.  Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

Authors:  Tamara Pilishvili; Catherine Lexau; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Arthur Reingold; Ann Thomas; William Schaffner; Allen S Craig; Philip J Smith; Bernard W Beall; Cynthia G Whitney; Matthew R Moore
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

8.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Authors:  Rosalyn J Singleton; Thomas W Hennessy; Lisa R Bulkow; Laura L Hammitt; Tammy Zulz; Debby A Hurlburt; Jay C Butler; Karen Rudolph; Alan Parkinson
Journal:  JAMA       Date:  2007-04-25       Impact factor: 56.272

9.  Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Authors:  Lauri A Hicks; Lee H Harrison; Brendan Flannery; James L Hadler; William Schaffner; Allen S Craig; Delois Jackson; Ann Thomas; Bernard Beall; Ruth Lynfield; Arthur Reingold; Monica M Farley; Cynthia G Whitney
Journal:  J Infect Dis       Date:  2007-10-04       Impact factor: 5.226

10.  Risk factors for pediatric invasive pneumococcal disease in the Intermountain West, 1996-2002.

Authors:  Maryam B Haddad; Christina A Porucznik; Kerry E Joyce; Anindya K De; Andrew T Pavia; Robert T Rolfs; Carrie L Byington
Journal:  Ann Epidemiol       Date:  2008-02       Impact factor: 3.797

View more
  6 in total

1.  Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era.

Authors:  Andrew D Wiese; Marie R Griffin; Yuwei Zhu; Edward F Mitchel; Carlos G Grijalva
Journal:  Vaccine       Date:  2016-11-07       Impact factor: 3.641

2.  The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.

Authors:  Krow Ampofo; Andrew T Pavia; Stockmann Chris; Adam L Hersh; Jeffrey M Bender; Anne J Blaschke; Hsin Yi Cindy Weng; Kent E Korgenski; Judy Daly; Edward O Mason; Carrie L Byington
Journal:  Pediatr Infect Dis J       Date:  2012-03       Impact factor: 2.129

3.  Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7.

Authors:  Liset Olarte; Krow Ampofo; Chris Stockmann; Edward O Mason; Judy A Daly; Andrew T Pavia; Carrie L Byington
Journal:  Pediatrics       Date:  2013-06-03       Impact factor: 7.124

4.  Clinical and Epidemiological Evidence of the Red Queen Hypothesis in Pneumococcal Serotype Dynamics.

Authors:  Chris Stockmann; Krow Ampofo; Andrew T Pavia; Anne J Blaschke; Edward O Mason; Angela P Presson; Larry J Forney; Carrie L Byington
Journal:  Clin Infect Dis       Date:  2016-06-09       Impact factor: 9.079

5.  Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah.

Authors:  Chris Stockmann; Krow Ampofo; Carrie L Byington; Francis Filloux; Adam L Hersh; Anne J Blaschke; Priscilla Cowan; Kent Korgenski; Edward O Mason; Andrew T Pavia
Journal:  Pediatrics       Date:  2013-08-26       Impact factor: 7.124

Review 6.  What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?

Authors:  Andrew T Pavia
Journal:  Infect Dis Clin North Am       Date:  2012-12-12       Impact factor: 5.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.